US FDA approves Vertex/CRISPR gene therapy for an inherited blood disorder

The headquarters of US biopharmaceutical company Vertex Pharmaceuticals in Boston, Massachusets, on November 4, 2023. The U.S. health regulator has approved Vertex Pharmaceuticals and CRISPR Therapeutics' gene therapy to treat a rare blood disorder requiring regular blood transfusions, in patients…#boston #massachusets #crisprtherapeutics #vertex #oppenheimer #hartajsingh
Source: Reuters: Health - Category: Consumer Health News Source Type: news